Work

Onivyde for the therapy of multiple solid tumors

Year: 2016
Type: review
Abstract: Drug delivery system based on nanobiotechnology can improve the pharmacokinetics and therapeutic index of chemotherapeutic agents, which has revolutionized tumor therapy. Onivyde, also known as MM-398 or PEP02, is a nanoliposomal formulation of irinotecan which has demonstrated encouraging anticancer activity across a broad range of malignancies, including pancreatic cancer, esophago-gastric cancer, and colorectal cancer. This up-to-date review not only focuses on the structure, pharmacokinetics, and pharmacogenetics of Onivyde but also summarizes clinical trials and recommends Onivyde for patients with advanced solid tumors.
Author: Haijun Zhang
Language: English
Subfield: Biomaterials
Open Access status: gold
Estimated APC paid: $2,836
OpenAlex ID: W2401094910
FWCI: 0.55
Cites: 36
Cited by: 205
Related to: 10